TMCnet News
Cubist Pharmaceuticals Names Robert Perez as CEO [Professional Services Close - Up](Professional Services Close - Up Via Acquire Media NewsEdge) Cubist Pharmaceuticals reported that its Board of Directors has selected Robert J. Perez as the Company's Chief Executive Officer, effective January 1, 2015. The company said that Perez, who currently serves as Cubist's President and Chief Operating Officer, will succeed Michael W. Bonney who is retiring from his current role as CEO on December 31, and will become non-executive Chair of Cubist's Board of Directors. In a release, Cubist Pharmaceuticals noted that current Board Chair, Kenneth M. Bate, will become Lead Independent Director. Perez has served in various senior positions at Cubist for 11 years. He was appointed COO in 2007, President in 2012 and has been a member of the Board since April 2014. "Under Mike Bonney's leadership, Cubist made the extraordinarily rare transition from struggling startup to global biotechnology leader with outstanding future growth potential," said Kenneth M. Bate, Chair of the Board of Directors at Cubist. "While delivering impressive results for shareholders and important therapies to patients, Mike has also helped create a dynamic company culture and a talented, diverse leadership team. We are very pleased that he will continue to serve on the Board, now as Chair. On behalf of the Board and everyone at Cubist, I thank Mike for his exceptional stewardship of Cubist over the past twelve years." Prior to joining Cubist, Perez served as Vice President of Biogen's CNS Business Unit where he was responsible for leading the U.S. neurology franchise. From 1995 to 2001 he served as a Regional Director, Director of Sales, and Avonex Commercial Executive at Biogen. From 1987 to 1995, Perez held various sales and marketing positions at Zeneca Pharmaceuticals. Perez is a Director at Amag Pharmaceuticals and from 2006 - 2009 served as a Director at Epix Pharmaceuticals. Cubist Pharmaceuticals is a global biopharmaceutical company. More information and complete details: www.cubist.com ((Comments on this story may be sent to [email protected])) (c) 2014 ProQuest Information and Learning Company; All Rights Reserved. |